Predictors of infusion reactions during infliximab treatment in patients with arthritis

類似資料

• Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs
  著者:: Crnkic Kapetanovic, Meliha, 等
  出版事項: (2013)
• Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
  著者:: Crnkic Kapetanovic, Meliha, 等
  出版事項: (2013)
• Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
  著者:: Crnkic, Meliha, 等
  出版事項: (2003)
• The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients
  著者:: Nagel, Johanna, 等
  出版事項: (2015)
• Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
  著者:: Kristensen, Lars Erik, 等
  出版事項: (2006)